Rewiring CD8+ T cell responses to PD-1 immune checkpoint blockade in PDAC via the inhibitory receptor PSGL-1

被引：0
|
作者：
Hope, Jennifer L.
Zhang, Yijuan
Hetrick, Hannah A. F.
Hernandez, Evelyn S. Sanchez
Romano, Gabriele
Roy, Sreeja
Lin, Michelle
Palete, Ashley B.
Maganti, Swetha
Otero, Dennis C.
Byrne, Katelyn T.
Commisso, Cosimo
Bradley, Linda M.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-B058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B058
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Contrasting roles of PSGL-1 and PD-1 in regulating T-cell exhaustion and function during chronic viral infection
    Viramontes, Karla M.
    Thone, Melissa N.
    de la Torre, Jamie-Jean
    Neubert, Emily N.
    Derogatis, Julia M.
    Garcia, Chris
    Henriquez, Monique L.
    Tinoco, Roberto
    JOURNAL OF VIROLOGY, 2025, 99 (03)
  • [42] COBLOCKADE OF TIGIT AND PD-1 OPTIMIZES ANTITUMOR CD8+ T-CELL RESPONSE
    不详
    CANCER DISCOVERY, 2022, 12 (05) : 1182 - 1182
  • [43] Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model
    Lukens, John R.
    Cruise, Michael W.
    Lassen, Matthew G.
    Hahn, Young S.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (07): : 4875 - 4884
  • [44] Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
    Assaf Magen
    Pauline Hamon
    Nathalie Fiaschi
    Brian Y. Soong
    Matthew D. Park
    Raphaël Mattiuz
    Etienne Humblin
    Leanna Troncoso
    Darwin D’souza
    Travis Dawson
    Joel Kim
    Steven Hamel
    Mark Buckup
    Christie Chang
    Alexandra Tabachnikova
    Hara Schwartz
    Nausicaa Malissen
    Yonit Lavin
    Alessandra Soares-Schanoski
    Bruno Giotti
    Samarth Hegde
    Giorgio Ioannou
    Edgar Gonzalez-Kozlova
    Clotilde Hennequin
    Jessica Le Berichel
    Zhen Zhao
    Stephen C. Ward
    Isabel Fiel
    Baijun Kou
    Michael Dobosz
    Lianjie Li
    Christina Adler
    Min Ni
    Yi Wei
    Wei Wang
    Gurinder S. Atwal
    Kunal Kundu
    Kamil J. Cygan
    Alexander M. Tsankov
    Adeeb Rahman
    Colles Price
    Nicolas Fernandez
    Jiang He
    Namita T. Gupta
    Seunghee Kim-Schulze
    Sacha Gnjatic
    Ephraim Kenigsberg
    Raquel P. Deering
    Myron Schwartz
    Thomas U. Marron
    Nature Medicine, 2023, 29 : 1389 - 1399
  • [45] Intratumoral dendritic cell-CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
    Magen, Assaf
    Hamon, Pauline
    Fiaschi, Nathalie
    Soong, Brian Y.
    Park, Matthew D.
    Mattiuz, Raphael
    Humblin, Etienne
    Troncoso, Leanna
    D'souza, Darwin
    Dawson, Travis
    Kim, Joel
    Hamel, Steven
    Buckup, Mark
    Chang, Christie
    Tabachnikova, Alexandra
    Schwartz, Hara
    Malissen, Nausicaa
    Lavin, Yonit
    Soares-Schanoski, Alessandra
    Giotti, Bruno
    Hegde, Samarth
    Ioannou, Giorgio
    Gonzalez-Kozlova, Edgar
    Hennequin, Clotilde
    Le Berichel, Jessica
    Zhao, Zhen
    Ward, Stephen C.
    Fiel, Isabel
    Kou, Baijun
    Dobosz, Michael
    Li, Lianjie
    Adler, Christina
    Ni, Min
    Wei, Yi
    Wang, Wei
    Atwal, Gurinder S.
    Kundu, Kunal
    Cygan, Kamil J.
    Tsankov, Alexander M.
    Rahman, Adeeb
    Price, Colles
    Fernandez, Nicolas
    He, Jiang
    Gupta, Namita T.
    Kim-Schulze, Seunghee
    Gnjatic, Sacha
    Kenigsberg, Ephraim
    Deering, Raquel P.
    Schwartz, Myron
    Marron, Thomas U.
    NATURE MEDICINE, 2023, 29 (6) : 1389 - 1399
  • [46] Impact of immune checkpoint protein expression in tumor cells and tumor infiltrating CD8+ T cells on clinical benefit from PD-1 blockade in metastatic clear cell renal cell carcinoma (mccRCC).
    Pigeon, Jean-Christophe
    Jegede, Opeyemi
    Mahoney, Kathleen M.
    Moreira, Raphael Brandao
    Novak, Jesse
    Conen, Hilla
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [47] Anlotinib enhanced CD8+ T cell infiltration via induction of CCL5 improves the efficacy of PD-1/PD-L1 blockade therapy in lung cancer
    Luo, Jie
    Cheng, Kebin
    Ji, Xianxiu
    Gao, Caixia
    Zhu, Ren
    Chen, Jiayi
    Xue, Wenjun
    Huang, Qi
    Xu, Qingqiang
    CANCER LETTERS, 2024, 591
  • [48] PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells
    Stecher, Carmen
    Battin, Claire
    Leitner, Judith
    Zettl, Markus
    Grabmeier-Pfistershammer, Katharina
    Hoeller, Christoph
    Zlabinger, Gerhard J.
    Steinberger, Peter
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [49] Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade
    Budimir, Natalija
    Thomas, Graham D.
    Dolina, Joseph S.
    Salek-Ardakani, Shahram
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (02) : 146 - 153
  • [50] PD-1/PD-L1 Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Bagley, Stephen J.
    Bauml, Joshua M.
    Langer, Corey J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (10) : 676 - 683
12345